NovoCure(MX:NVCRN)
MX$248.490.00 (0.00%)
MX:NVCRN
NovoCure earnings date
MX$248.49
At close:0.00 (0.00%)
NovoCure (NVCRN) Q2 2023 Earnings Report
1 Followers
MX:NVCRN Q2 2023 EPS Results
- Actual EPS
- -MXN 10.04
- Consensus EPS
- -MXN 9.29
- Beat/Miss
- Missed by -MXN 0.74
- One Year Ago EPS
- -MXN 4.28
MX:NVCRN Q2 2023 Revenue Results
- Actual Revenue
- MXN 2.34B
- Expected Revenue
- MXN 2.31B
- Beat/Miss
- Beat by +MXN 33.46M
- YoY Revenue Growth
- -10.52%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 07/27/2023
- Time
- Before Open
- Conference Call
- Thursday, July 27, 2023
MX:NVCRN Upcoming Earnings
NovoCure's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
MX:NVCRN Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVCRN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -4.00- | -4.09 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -4.37-1.67 | -6.13 | 72.73% (+4.46) | |
| Jul 23, 2026 | 2026 (Q2) | -6.17-2.42 | -6.69 | 63.89% (+4.28) | |
| Apr 30, 2026 | 2026 (Q1) | -9.52-11.53 | -5.76 | -100.00% (-5.76) | |
| Feb 26, 2026 | 2025 (Q4) | -7.64-4.09 | -11.34 | 63.93% (+7.25) | |
| Oct 30, 2025 | 2025 (Q3) | -7.81-6.13 | -5.21 | -17.86% (-0.93) | |
| Jul 24, 2025 | 2025 (Q2) | -7.14-6.69 | -5.76 | -16.13% (-0.93) | |
| Apr 24, 2025 | 2025 (Q1) | -8.63-5.76 | -6.69 | 13.89% (+0.93) | |
| Feb 27, 2025 | 2024 (Q4) | -6.39-11.34 | -8.37 | -35.56% (-2.97) | |
| Oct 30, 2024 | 2024 (Q3) | -6.21-5.21 | -8.55 | 39.13% (+3.35) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
